Probiotic supplementation influences faecal short chain fatty acids in infants at high risk for eczema

Beneficial Microbes

Volumn 6, Issue 6, 2015, Pages 783-790

  Kim, H K ^a,b   Rutten, N B M M ^c   Besseling van der Vaart, I ^b   Niers, L E M ^d   Choi, Y H ^a   Rijkers, G T ^c,e   van Hemert, S ^b  

^a LEIDEN UNIVERSITY   (Netherlands)

^b WINCLOVE PROBIOTICS   (Netherlands)

^c ST ANTONIUS HOSPITAL   (Netherlands)

^d MÁXIMA MEDICAL CENTER   (Netherlands)

^e University College Roosevelt   (Netherlands)

Author keywords

atopy; intestinal microbiota; metabolites; probiotics

Indexed keywords

ALANINE; FATTY ACID DERIVATIVE; GALACTOSE; GLUCOSE; LACTIC ACID; LACTOSE; PHENYLALANINE; PLACEBO; PROBIOTIC AGENT; SHORT CHAIN FATTY ACID; SUCCINIC ACID; VOLATILE FATTY ACID;

ARTICLE; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM BIFIDUM; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ECZEMA; FATTY ACID ANALYSIS; FECES ANALYSIS; FEMALE; HIGH RISK POPULATION; HUMAN; IMMUNE SYSTEM; INFANT; LACTOCOCCUS LACTIS; MICROBIAL METABOLISM; NONHUMAN; ORGANOGENESIS; OUTCOME ASSESSMENT; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; RAT; TREATMENT RESPONSE; CHEMISTRY; FECES; MALE; NEWBORN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PREGNANCY;

CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; ECZEMA; FATTY ACIDS, VOLATILE; FECES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PLACEBOS; PREGNANCY; PROBIOTICS;

EID: 84949744739     PISSN: 18762883     EISSN: 18762891     Source Type: Journal    
DOI: 10.3920/BM2015.0056     Document Type: Article

References (40)

1. Abrahamsson, T.R., Jakobsson, H.E., Andersson, A.F., Bjorksten, B., Engstrand, L. and Jenmalm, M.C., 2014. Low gut microbiota diversity in early infancy precedes asthma at school age. Clinical and Experimental Allergy 44: 842-850.
2. Arpaia, N., Campbell, C., Fan, X., Dikiy, S., Van der Veeken, J., De Roos, P., Liu, H., Cross, J.R., Pfeffer, K., Coffer, P.J. and Rudensky, A.Y., 2013. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504: 451-455.
3. Azad, M.B., Coneys, J.G., Kozyrskyj, A.L., Field, C.J., Ramsey, C.D., Becker, A.B., Friesen, C., Abou-Setta, A.M. and Zarychanski, R., 2013. Probiotic supplementation during pregnancy or infancy for the prevention of asthma and wheeze: systematic review and metaanalysis. BMJ 347: f6471.
4. Bisgaard, H., Li, N., Bonnelykke, K., Chawes, B.L., Skov, T., Paludan- Muller, G., Stokholm, J., Smith, B. and Krogfelt, K.A., 2011. Reduced diversity of the intestinal microbiota during infancy is associated with increased risk of allergic disease at school age. Journal of Allergy and Clinical Immunology 128: 646-652 e641-645.
5. Bjorksten, B., Sepp, E., Julge, K., Voor, T. and Mikelsaar, M., 2001.Allergy development and the intestinal microflora during the first year of life. Journal of Allergy and Clinical Immunology 108: 516-520.
6. Bottcher, M.F., Nordin, E.K., Sandin, A., Midtvedt, T. and Bjorksten, B., 2000. Microflora-associated characteristics in faeces from allergic and nonallergic infants. Clinical and Experimental Allergy 30: 1590-1596.
7. Brennan, L., 2008. Session 2: Personalised nutrition. Metabolomic applications in nutritional research. Proceedings of the Nutrition Society 67: 404-408.
8. Bylesjo, M., Rantalainen, M., Cloarec, O., Nicholson, J.K., Holmes, E. and Trygg, J., 2006. OPLS discriminant analysis: combining the strengths of PLS-DA and SIMCA classification. Journal of Chemometrics 20: 341-351.
9. De Preter, V., Ghebretinsae, A.H., Abrahantes, J.C., Windey, K., Rutgeerts, P. and Verbeke, K., 2011. Impact of the synbiotic combination of Lactobacillus casei shirota and oligofructoseenriched inulin on the fecal volatile metabolite profile in healthy subjects. Molecular Nutrition and Food Research 55: 714-722.
10. Elazab, N., Mendy, A., Gasana, J., Vieira, E.R., Quizon, A. and Forno, E., 2013. Probiotic Administration in Early Life, Atopy, and Asthma: A Meta-analysis of Clinical Trials. Pediatrics 132: e666-676.
11. Food and Agriculture Organization of the United Nations/World Health Organization (FAO/WHO), 2001. Evaluation of health and nutritional properties of powder milk and live lactic acid bacteria. Available at: http://tinyurl.com/8bccc3r.
12. Fishbein, A.B. and Fuleihan, R.L., 2012. The hygiene hypothesis revisited: does exposure to infectious agents protect us from allergy? Current Opinion in Pediatrics 24: 98-102.
13. Floch, M.H., Walker, W.A., Madsen, K., Sanders, M.E., Macfarlane, G.T., Flint, H.J., Dieleman, L.A., Ringel, Y., Guandalini, S., Kelly, C.P.and Brandt, L.J., 2011. Recommendations for probiotic use-2011 update. Journal of Clinical Gastroenterology 45 Suppl: S168-171.
14. Furusawa, Y., Obata, Y., Fukuda, S., Endo, T.A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T., Takahashi, M., Fukuda, N.N., Murakami, S., Miyauchi, E., Hino, S., Atarashi, K., Onawa, S., Fujimura, Y., Lockett, T., Clarke, J.M., Topping, D.L., Tomita, M., Hori, S., Ohara, O., Morita, T., Koseki, H., Kikuchi, J., Honda, K., Hase, K. and Ohno, H., 2013. Commensal microbederived butyrate induces the differentiation of colonic regulatory T cells. Nature 504: 446-450.
15. Gorissen, D.M., Rutten, N.B., Oostermeijer, C.M., Niers, L.E., Hoekstra, M.O., Rijkers, G.T. and van der Ent, C.K., 2014. Preventive effects of selected probiotic strains on the development of asthma and allergic rhinitis in childhood. The Panda study. Clinical and Experimental Allergy 44: 1431-1433.
16. Hill, C., Guarner, F., Reid, G., Gibson, G.R., Merenstein, D.J., Pot, B., Morelli, L., Canani, R.B., Flint, H.J., Salminen, S., Calder, P.C. and Sanders, M.E., 2014. Expert consensus document: the International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology and Hepatology 11: 506-514.
17. Ismail, I.H., Licciardi, P.V. and Tang, M.L., 2013. Probiotic effects in allergic disease. Journal of Paediatrics and Child Health 49: 709-715.
18. Jacobs, D.M., Deltimple, N., Van Velzen, E., Van Dorsten, F.A., Bingham, M., Vaughan, E.E. and Van Duynhoven, J., 2008. 1H NMR metabolite profiling of feces as a tool to assess the impact of nutrition on the human microbiome. NMR in Biomedicine 21: 615-626.
19. Klein, A., Friedrich, U., Vogelsang, H. and Jahreis, G., 2008.Lactobacillus acidophilus 74-2 and Bifidobacterium animalis subsp lactis DGCC 420 modulate unspecific cellular immune response in healthy adults. European Journal of Clinical Nutrition 62: 584-593.
20. Kramer, A., Bekeschus, S., Broker, B.M., Schleibinger, H., Razavi, B.and Assadian, O., 2013. Maintaining health by balancing microbial exposure and prevention of infection: the hygiene hypothesis versus the hypothesis of early immune challenge. Journal of Hospital Infection 83 Suppl. 1: S29-S34.
21. Le Gall, G., Noor, S.O., Ridgway, K., Scovell, L., Jamieson, C., Johnson, I.T., Colquhoun, I.J., Kemsley, E.K. and Narbad, A., 2011.Metabolomics of fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome. Journal of Proteome Research 10: 4208-4218.
22. Leonel, A.J. and Alvarez-Leite, J.I., 2012. Butyrate: implications for intestinal function. Current Opinion in Clinical Nutrition and Metabolic Care 15: 474-479.
23. Lindon, J.C., Holmes, E. and Nicholson, J.K., 2007. Metabonomics in pharmaceutical R&D. FEBS Journal 274: 1140-1151.
24. Marchesi, J.R., Holmes, E., Khan, F., Kochhar, S., Scanlan, P., Shanahan, F., Wilson, I.D. and Wang, Y., 2007. Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. Journal of Proteome Research 6: 546-551.
25. Martin, F.P., Wang, Y., Sprenger, N., Yap, I.K., Lundstedt, T., Lek, P., Rezzi, S., Ramadan, Z., Van Bladeren, P., Fay, L.B., Kochhar, S., Lindon, J.C., Holmes, E. and Nicholson, J.K., 2008. Probiotic modulation of symbiotic gut microbial-host metabolic interactions in a humanized microbiome mouse model. Molecular Systems Biology 4: 157.
26. Monleon, D., Morales, J.M., Barrasa, A., Lopez, J.A., Vazquez, C. and Celda, B., 2009. Metabolite profiling of fecal water extracts from human colorectal cancer. NMR in Biomedicine 22: 342-348.
27. Nicholson, J.K., Holmes, E. and Wilson, I.D., 2005. Gut microorganisms, mammalian metabolism and personalized health care. Nature Reviews Microbiology 3: 431-438.
28. Niers, L., Martin, R., Rijkers, G., Sengers, F., Timmerman, H., Van Uden, N., Smidt, H., Kimpen, J. and Hoekstra, M., 2009. The effects of selected probiotic strains on the development of eczema (the PandA study). Allergy 64: 1349-1358.
29. Niers, L.E., Hoekstra, M.O., Timmerman, H.M., Van Uden, N.O., De Graaf, P.M., Smits, H.H., Kimpen, J.L. and Rijkers, G.T., 2007.Selection of probiotic bacteria for prevention of allergic diseases: immunomodulation of neonatal dendritic cells. Clinical and Experimental Immunology 149: 344-352.
30. Nylund, L., Nermes, M., Isolauri, E., Salminen, S., De Vos, W.M. and Satokari, R., 2015. Severity of atopic disease inversely correlates with intestinal microbiota diversity and butyrate-producing bacteria. Allergy 70: 241-244.
31. Panduru, M., Panduru, N.M., Salavastru, C.M. and Tiplica, G.S., 2015.Probiotics and primary prevention of atopic dermatitis: a metaanalysis of randomized controlled studies. Journal of the European Academy of Dermatology and Venereology 29: 232-242.
32. Quigley, E.M., 2013. Gut bacteria in health and disease. Gastroenterology and Hepatology 9: 560-569.
33. Rosenfeldt, V., Benfeldt, E., Valerius, N.H., Paerregaard, A. and Michaelsen, K.F., 2004. Effect of probiotics on gastrointestinal symptoms and small intestinal permeability in children with atopic dermatitis. Journal of Pediatrics 145: 612-616.
34. Rutten, N.B.M.M., Gorissen, D.M.W., Eck, A., Niers, L.E.M., Vlieger, A.M., Besseling-van der Vaart, I., Budding, A.E., Savelkoul, P.H.M., Van der Ent, C.K. and Rijkers, G.T., 2015. Long term development of gut microbiota composition in atopic children: impact of probiotics. PLoS ONE 10: e0137681.
35. Sanders, M.E., Guarner, F., Guerrant, R., Holt, P.R., Quigley, E.M., Sartor, R.B., Sherman, P.M. and Mayer, E.A., 2013. An update on the use and investigation of probiotics in health and disease. Gut 62: 787-796.
36. Sandin, A., Braback, L., Norin, E. and Bjorksten, B., 2009. Faecal short chain fatty acid pattern and allergy in early childhood. Acta Paediatrica 98: 823-827.
37. Topping, D.L. and Clifton, P.M., 2001. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiological Reviews 81: 1031-1064.
38. Van Zanten, G.C., Knudsen, A., Roytio, H., Forssten, S., Lawther, M., Blennow, A., Lahtinen, S.J., Jakobsen, M., Svensson, B. and Jespersen, L., 2012. The effect of selected synbiotics on microbial composition and short-chain fatty acid production in a model system of the human colon. PloS One 7: e47212.
39. Vitali, B., Ndagijimana, M., Cruciani, F., Carnevali, P., Candela, M., Guerzoni, M.E. and Brigidi, P., 2010. Impact of a synbiotic food on the gut microbial ecology and metabolic profiles. BMC Microbiology 10: 4.
40. Yen, S., McDonald, J.A., Schroeter, K., Oliphant, K., Sokolenko, S., Blondeel, E.J., Allen-Vercoe, E. and Aucoin, M.G., 2015.Metabolomic analysis of human fecal microbiota: a comparison of feces-derived communities and defined mixed communities. Journal of Proteome Research 14: 1472-1482.